Altrius Capital Management Inc Has $6.40 Million Stock Position in Roche Holding AG (OTCMKTS:RHHBY)

Altrius Capital Management Inc increased its stake in Roche Holding AG (OTCMKTS:RHHBY) by 0.3% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 183,448 shares of the company’s stock after purchasing an additional 603 shares during the quarter. Roche comprises about 1.7% of Altrius Capital Management Inc’s holdings, making the stock its 23rd largest position. Altrius Capital Management Inc’s holdings in Roche were worth $6,399,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Brooklyn Investment Group purchased a new position in shares of Roche during the 3rd quarter worth approximately $40,000. IHT Wealth Management LLC bought a new stake in Roche during the third quarter worth approximately $236,000. Verity Asset Management Inc. bought a new position in Roche in the 3rd quarter valued at $253,000. Canopy Partners LLC increased its stake in shares of Roche by 4.6% during the third quarter. Canopy Partners LLC now owns 7,772 shares of the company’s stock valued at $310,000 after buying an additional 344 shares during the period. Finally, Confluence Investment Management LLC boosted its position in Roche by 26.3% during the 4th quarter. Confluence Investment Management LLC now owns 13,981 shares of the company’s stock valued at $488,000 after acquiring an additional 2,910 shares in the last quarter.

Analyst Upgrades and Downgrades

RHHBY has been the subject of a number of recent research reports. Sanford C. Bernstein upgraded Roche to a “strong-buy” rating in a research note on Thursday, January 30th. Morgan Stanley began coverage on shares of Roche in a report on Wednesday, February 12th. They issued an “equal weight” rating on the stock. Finally, UBS Group raised Roche from a “hold” rating to a “strong-buy” rating in a research note on Thursday, February 13th. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating, one has assigned a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold”.

Roche Stock Performance

RHHBY stock opened at $41.44 on Friday. Roche Holding AG has a 52 week low of $29.20 and a 52 week high of $42.43. The company has a debt-to-equity ratio of 0.86, a current ratio of 1.26 and a quick ratio of 0.97. The company’s 50-day moving average price is $38.09 and its 200 day moving average price is $38.42.

Roche Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.